Clearside Biomedical (FRA:CLM) Preferred Dividends : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Clearside Biomedical Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Clearside Biomedical's preferred dividends for the three months ended in Mar. 2025 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

Clearside Biomedical Preferred Dividends Historical Data

The historical data trend for Clearside Biomedical's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearside Biomedical Preferred Dividends Chart

Clearside Biomedical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Preferred Dividends

Get a 7-Day Free Trial

Clearside Biomedical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Clearside Biomedical Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Clearside Biomedical (FRA:CLM) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Clearside Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearside Biomedical Inc (FRA:CLM) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

CLSD:USA

Address

900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005

Website

https://www.clearsidebio.com

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.